243 related articles for article (PubMed ID: 25751720)
1. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
3. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
4. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
[TBL] [Abstract][Full Text] [Related]
5. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
7. The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis.
Torok MR; Miller WC; Hobbs MM; Macdonald PD; Leone PA; Schwebke JR; Seña AC
Sex Transm Dis; 2009 Jun; 36(6):336-40. PubMed ID: 19556926
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R
AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681
[TBL] [Abstract][Full Text] [Related]
11. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
[TBL] [Abstract][Full Text] [Related]
12. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
[TBL] [Abstract][Full Text] [Related]
13. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
14. Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.
Socías ME; Duff P; Shoveller J; Montaner JSG; Nguyen P; Ogilvie G; Shannon K
Sex Transm Infect; 2017 Jun; 93(4):284-289. PubMed ID: 27821613
[TBL] [Abstract][Full Text] [Related]
15. Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.
Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD
Obstet Gynecol; 2013 Mar; 121(3):593-600. PubMed ID: 23635623
[TBL] [Abstract][Full Text] [Related]
16. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
[TBL] [Abstract][Full Text] [Related]
17. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
18. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091
[TBL] [Abstract][Full Text] [Related]
19. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
Boodhram R; Moodley D; Abbai N; Ramjee G
BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
[TBL] [Abstract][Full Text] [Related]
20. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial.
Stringer EM; Levy J; Sinkala M; Chi BH; Matongo I; Chintu N; Stringer JS
AIDS; 2009 Jul; 23(11):1377-82. PubMed ID: 19448528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
